InsidersTradesSigma
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (4 ops.)
Insider track record
ExecutiveDisclosed buys
0
Disclosed sells
4
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Discover the complete record of transactions filed by Ball Bryan, Directeur Qualité. Insider active across 3 companies, notably Intercept Pharmaceuticals, INC.. Cumulatively, 11 disclosures have been published. Breakdown: 0 buy · 4 sells. Total volume traded: €535k. Activity tracked since 11 January 2022. The latest transaction was disclosed on 14 April 2026 (Cession). Regulator: SEC (Form 4). All data is accessible without signup.
Companies and markets linked to Ball Bryan
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations11 total
26,389 shares@ US$3.4621.4% of flowCommon StockSEC:0001766522-26-000011:0
92,460 shares@ US$3.6478.6% of flowCommon StockSEC:0001766522-26-000011:1
50,000 shares@ US$3.5728.5% of flowCommon StockSEC:0001766522-26-000009:0
6,596 shares@ US$3.433.6% of flowCommon StockSEC:0001766522-26-000009:1
366,532 sharesCommon StockSEC:0001766522-26-000005:0
5,000 sharesCommon StockSEC:0001766522-26-000002:0
5,000 sharesCommon StockSEC:0001415889-25-006676:0
436 shares@ US$14.577.2% of flowCommon StockSEC:0001104659-22-079500:0
531 shares@ US$17.1910.3% of flowCommon StockSEC:0001104659-22-045468:0
3,600 shares0Common StockSEC:0001104659-22-009549:0
2,455 shares@ US$16.8344.8% of flowCommon StockSEC:0001104659-22-004113:0
11 of 11 declarations
About Ball Bryan
BALL BRYAN is the Chief Quality Officer and Senior Vice President of Operations at INTERCEPT PHARMACEUTICALS, INC. He oversees quality and operational efficiency initiatives, ensuring that the company meets the highest standards in its processes.
